Concepedia

Leslie Smetzer

LS

Statistics

Publications

13

Citations

1.1K

H-Index

12

Active since

1995

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Brooke Army Medical Center

Wilford Hall Ambulatory Surgical Center

Texas Oncology

Leslie Smetzer is an author at The University of Texas at San Antonio Health Science Center specializing in pharmacology, medicine, and oncology.

Publications per year

1995–2012

13

Publications

13

The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer

Toshio Shimizu, Anthony W. Tolcher, Kyriakos P. Papadopoulos et al. · Clinical Cancer Research · 2012 · 432 citations

, , +17

Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.

Richard L. Schilsky, John Hohneker, Mark J. Ratain et al. · Journal of Clinical Oncology · 1998 · 105 citations

, , +17

A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077.

Carolyn D. Britten, Eric K. Rowinsky, Sharyn D. Baker et al. · PubMed · 2000 · 103 citations

, , +17

Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy.

Agop Y. Bedikian, Geoffrey R. Weiss, Sewa S. Legha et al. · Journal of Clinical Oncology · 1995 · 95 citations

, , +15

Phase I and Pharmacologic Study of the Specific Matrix Metalloproteinase Inhibitor BAY 12-9566 on a Protracted Oral Daily Dosing Schedule in Patients With Solid Malignancies

Eric K. Rowinsky, Rachel Humphrey, Lisa A. Hammond et al. · Journal of Clinical Oncology · 2000 · 85 citations

, , +14

1–5 of 13